Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A couple of China-based EV giants had good news to share in spite of a weakened consumer at home and fresh tariffs from the EU and Canada.
Mizuho found that both low- and high-income Americans alike are trying to get as thrifty as possible, reducing spend.
ExxonMobil forecast that oil demand will remain above 100 million barrels per day in 2050, roughly the same as current levels.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
In addition to offering mobile headquarters for families on vacation, recreational vehicle sales are a pretty good indicator of the economy.
Peloton reported sales growth of 0.2% in the latest quarter, its first quarter of year-over-year revenue growth since late 2021.
Though generative AI could make game development faster and easier, the industry is divided on where AI fits into the picture.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Both Target and TJ Maxx posted stellar earnings results on the strength of the incredibly resilient US consumer.
Antitrust regulators in India flagged Disney’s $8.5 billion merger with Reliance for competition concerns in cricket broadcast rights.
The European Commission on Tuesday solidified new tariffs for electric vehicles imported from China. The actual numbers aren’t harsh.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.